{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:21:35Z","timestamp":1771478495826,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.exger.2012.07.002","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T10:35:54Z","timestamp":1342175754000},"page":"887-891","source":"Crossref","is-referenced-by-count":58,"title":["Pharmacological prevention and treatment of vascular dementia: Approaches and perspectives"],"prefix":"10.1016","volume":"47","author":[{"given":"Andrius","family":"Baskys","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-xiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2012.07.002_bb9000","first-page":"CD003154","article-title":"Memantine for dementia","volume":"3","author":"Areosa","year":"2005","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"10.1016\/j.exger.2012.07.002_bb0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000266625.31615.f6","article-title":"Galantamine treatment of vascular dementia: a randomized trial","volume":"69","author":"Auchus","year":"2007","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.exger.2012.07.002_bb0010","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1185\/03007990802328142","article-title":"Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study","volume":"24","author":"Ballard","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"issue":"3","key":"10.1016\/j.exger.2012.07.002_bb0015","first-page":"327","article-title":"Vascular dementia: pharmacological treatment approaches and perspectives","volume":"2","author":"Baskys","year":"2007","journal-title":"Clin. Interv. Aging"},{"issue":"1","key":"10.1016\/j.exger.2012.07.002_bb0020","first-page":"CD003120","article-title":"Ginkgo biloba for cognitive impairment and dementia","author":"Birks","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.exger.2012.07.002_bb0025","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.STR.0000091396.95360.E1","article-title":"Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial","volume":"34","author":"Black","year":"2003","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.exger.2012.07.002_bb0030","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1742-1241.2011.02810.x","article-title":"The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies","volume":"65","author":"Chang-Quan","year":"2011","journal-title":"Int. J. Clin. Pract."},{"issue":"1\u20133","key":"10.1016\/j.exger.2012.07.002_bb0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cbi.2008.05.023","article-title":"[+]-Huperzine A treatment protects against N-methyl-D-aspartate-induced seizure\/status epilepticus in rats","volume":"175","author":"Coleman","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.exger.2012.07.002_bb0040","series-title":"Cochrane Database of Systematic Reviews","article-title":"Galantamine for vascular cognitive impairment","author":"Craig","year":"2009"},{"issue":"4","key":"10.1016\/j.exger.2012.07.002_bb0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(08)70046-2","article-title":"Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL","volume":"7","author":"Dichgans","year":"2008","journal-title":"Lancet Neurol."},{"issue":"7367","key":"10.1016\/j.exger.2012.07.002_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","article-title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","volume":"478","author":"Ehret","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.exger.2012.07.002_bb0055","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association\/american stroke association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.exger.2012.07.002_bb0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-0031-1291217","article-title":"Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761\u00ae in Alzheimer's disease and vascular dementia: results from a randomized controlled trial","volume":"45","author":"Ihl","year":"2012","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"10.1016\/j.exger.2012.07.002_bb0065","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(07)70195-3","article-title":"Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials","volume":"6","author":"Kavirajan","year":"2007","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.exger.2012.07.002_bb0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1592\/phco.31.5.490","article-title":"Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis","volume":"31","author":"Kellermann","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.exger.2012.07.002_bb0075","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11910-009-0065-y","article-title":"Vascular dementia: a review of recent evidence for prevention and treatment","volume":"9","author":"Kirshner","year":"2009","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.exger.2012.07.002_bb0080","series-title":"Cochrane Database of Systematic Reviews","article-title":"Huperzine A for Alzheimer's disease","author":"Li","year":"2008"},{"key":"10.1016\/j.exger.2012.07.002_bb0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2147\/VHRM.S7343","article-title":"Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review","volume":"6","author":"Ligthart","year":"2010","journal-title":"Vasc. Health Risk Manag."},{"issue":"1\u20132","key":"10.1016\/j.exger.2012.07.002_bb0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2010.04.001","article-title":"The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: a meta-analysis","volume":"294","author":"Liu","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.exger.2012.07.002_bb0095","series-title":"Cochrane Database of Systematic Reviews","article-title":"Donepezil for vascular cognitive impairment","author":"Malouf","year":"2009"},{"key":"10.1016\/j.exger.2012.07.002_bb0100","series-title":"Cochrane Database of Systematic Reviews","article-title":"Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people","author":"Malouf","year":"2008"},{"key":"10.1016\/j.exger.2012.07.002_bb0105","series-title":"Cochrane Database of Systematic Reviews","article-title":"Statins for the prevention of dementia","author":"McGuinness","year":"2009"},{"issue":"4","key":"10.1016\/j.exger.2012.07.002_bb0115","first-page":"CD004034","article-title":"Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia","author":"McGuinness","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.exger.2012.07.002_bb0110","series-title":"Cochrane Database of Systematic Reviews","article-title":"Statins for the treatment of dementia","author":"McGuinness","year":"2010"},{"key":"10.1016\/j.exger.2012.07.002_bb0120","series-title":"Cochrane Database of Systematic Reviews","article-title":"Memantine for dementia","author":"McShane","year":"2009"},{"issue":"2","key":"10.1016\/j.exger.2012.07.002_bb0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1447-0594.2009.00579.x","article-title":"Systematic review of statins for the prevention of vascular dementia or dementia","volume":"10","author":"Muangpaisan","year":"2010","journal-title":"Geriatr. Gerontol. Int."},{"issue":"7","key":"10.1016\/j.exger.2012.07.002_bb0130","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.STR.0000020094.08790.49","article-title":"Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)","volume":"33","author":"Orgogozo","year":"2002","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.exger.2012.07.002_bb0135","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.exger.2012.07.002_bb0140","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jnnp.72.5.567","article-title":"Benefits and risks of folic acid to the nervous system","volume":"72","author":"Reynolds","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.exger.2012.07.002_bb0145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0025-7125(02)00008-1","article-title":"Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention","volume":"86","author":"Roman","year":"2002","journal-title":"Med. Clin. North Am."},{"issue":"6","key":"10.1016\/j.exger.2012.07.002_bb0150","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/STROKEAHA.109.570077","article-title":"Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size","volume":"41","author":"Roman","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.exger.2012.07.002_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/STROKEAHA.111.628768","article-title":"Genome-wide association study of vascular dementia","volume":"43","author":"Schrijvers","year":"2012","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.exger.2012.07.002_bb0160","first-page":"CD008191","article-title":"Antidepressants for agitation and psychosis in dementia","author":"Seitz","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.exger.2012.07.002_bb0165","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjopharm.2009.11.001","article-title":"Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review","volume":"7","author":"Shah","year":"2009","journal-title":"Am. J. Geriatr. Pharmacother."},{"issue":"7","key":"10.1016\/j.exger.2012.07.002_bb0170","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/gps.2572","article-title":"Hypertension is a potential risk factor for vascular dementia: systematic review","volume":"26","author":"Sharp","year":"2011","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.exger.2012.07.002_bb0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2796.2010.02281.x","article-title":"Physical activity and risk of cognitive decline: a meta-analysis of prospective studies","volume":"269","author":"Sofi","year":"2011","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.exger.2012.07.002_bb0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00702-009-0189-x","article-title":"Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis","volume":"116","author":"Wang","year":"2009","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.exger.2012.07.002_bb0180","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0029-1242817","article-title":"Effectiveness of standardized ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: a bivariate random effect meta-analysis","volume":"43","author":"Wang","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.exger.2012.07.002_bb0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2318-10-14","article-title":"Effects of Ginkgo biloba in dementia: systematic review and meta-analysis","volume":"10","author":"Weinmann","year":"2010","journal-title":"BMC Geriatr."},{"issue":"6","key":"10.1016\/j.exger.2012.07.002_bb0195","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004850-200211000-00005","article-title":"A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)","volume":"17","author":"Wilcock","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.exger.2012.07.002_bb0200","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/01.WNL.0000078943.50032.FC","article-title":"Donepezil in vascular dementia: a randomized, placebo-controlled study","volume":"61","author":"Wilkinson","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.exger.2012.07.002_bb0205","first-page":"CD001296","article-title":"Aspirin for vascular dementia","author":"Williams","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.exger.2012.07.002_bb0210","first-page":"1214","article-title":"Effectiveness of polydrug therapy for senile dementia","volume":"8","author":"Zhou","year":"2004","journal-title":"Chin. J. Clin. Rehabil."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556512001921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556512001921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T19:34:04Z","timestamp":1714160044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556512001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0531556512001921"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2012.07.002","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}